You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 7, July 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (25)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

From Inflammation to Neoplasia

Mycosis Fungoides Evolves From Reactive Inflammatory Conditions (Lymphoid Infiltrates) Transforming Into Neoplastic Plaques and Tumors

Arch Dermatol. 2001;137:949-952.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE ARTICLE by Rubegni et al1 describes the cytokine production profile of peripheral blood mononuclear cells (PBMCs) in patients with large-plaque parapsoriasis. Interleukin 4 (IL-4) and interferon gamma (IFN-{gamma}) were measured in PBMCs following phytohemagglutinin antigen (PHA) stimulation in patients with large-plaque parapsoriasis (LPP), patients with stage Ib (more than 10% of the body surface involved) mycosis fungoides (MF), and healthy controls. One difficulty with this approach is the bias in differentiating LPP and early patch-stage MF. As acknowledged by the authors,1 discrimination between the 2 diseases emerges as increasingly difficult. It is not clear why 4 patients (40% in their series of patients with LPP, Nos. 4, 5, 8, and 9) whose cells exhibited T-cell receptor gamma (TCR-{gamma}) rearrangement were included in the LPP group instead of with the early MF group. Furthermore, the question raised is how many of the patients diagnosed as having early MF . . . [Full Text of this Article]

DEFINITIONS: INFLAMMATION VS NEOPLASIA


PRENEOPLASTIC CONDITIONS AND PPP DO NOT EXHIBIT DIAGNOSTIC CRITERIA OF MF

THE PATHOGENESIS OF CUTANEOUS LYMPHOMAS: WHEN DOES MF START?

CYTOGENETIC STUDIES SUPPORT THE CONCEPT OF A MULTISTEP EVOLUTION OF CTCL

CONCLUSIONS


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Association Between Zalcitabine Therapy for Human Immunodeficiency Virus and Granuloma Annulare?
Pablo F. Peñas, María Jones-Caballero, and Amaro García-Díez
Arch Dermatol. 2001;137(7):964.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cutaneous T-Cell Lymphoid Dyscrasia: A Unifying Term for Idiopathic Chronic Dermatoses With Persistent T-Cell Clones
Guitart and Magro
Arch Dermatol 2007;143:921-932.
ABSTRACT | FULL TEXT  

Beyond Clonal Detection: Defining the T-Cell Clone
Guitart
Arch Dermatol 2005;141:1159-1160.
FULL TEXT  

Proliferation of CD30+ T-Helper 2 Lymphoma Cells Can Be Inhibited by CD30 Receptor Cross-Linking with Recombinant CD30 Ligand
Willers et al.
Clin. Cancer Res. 2003;9:2744-2754.
ABSTRACT | FULL TEXT  

Density of neoplastic lymphoid infiltrate, CD8+ T cells, and CD1a+ dendritic cells in mycosis fungoides
Goteri et al.
J. Clin. Pathol. 2003;56:453-458.
ABSTRACT | FULL TEXT  

T-Cell Clonality in Pityriasis Lichenoides: Evidence for a Premalignant or Reactive Immune Disorder?
Kadin
Arch Dermatol 2002;138:1089-1090.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.